Epigenetic protein families: a new frontier for drug discovery.

Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as...

Full description

Bibliographic Details
Main Authors: Arrowsmith, C, Bountra, C, Fish, P, Lee, K, Schapira, M
Format: Journal article
Language:English
Published: 2012
_version_ 1826282780721414144
author Arrowsmith, C
Bountra, C
Fish, P
Lee, K
Schapira, M
author_facet Arrowsmith, C
Bountra, C
Fish, P
Lee, K
Schapira, M
author_sort Arrowsmith, C
collection OXFORD
description Epigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones. Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-containing proteins and proteins that bind to methylated histones. These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains. In this article, we discuss the known links with disease, basic molecular mechanisms of action and recent progress in the pharmacological modulation of each class of proteins.
first_indexed 2024-03-07T00:49:01Z
format Journal article
id oxford-uuid:85b763a1-df21-471b-bc04-205b8f810520
institution University of Oxford
language English
last_indexed 2024-03-07T00:49:01Z
publishDate 2012
record_format dspace
spelling oxford-uuid:85b763a1-df21-471b-bc04-205b8f8105202022-03-26T21:59:24ZEpigenetic protein families: a new frontier for drug discovery.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:85b763a1-df21-471b-bc04-205b8f810520EnglishSymplectic Elements at Oxford2012Arrowsmith, CBountra, CFish, PLee, KSchapira, MEpigenetic regulation of gene expression is a dynamic and reversible process that establishes normal cellular phenotypes but also contributes to human diseases. At the molecular level, epigenetic regulation involves hierarchical covalent modification of DNA and the proteins that package DNA, such as histones. Here, we review the key protein families that mediate epigenetic signalling through the acetylation and methylation of histones, including histone deacetylases, protein methyltransferases, lysine demethylases, bromodomain-containing proteins and proteins that bind to methylated histones. These protein families are emerging as druggable classes of enzymes and druggable classes of protein-protein interaction domains. In this article, we discuss the known links with disease, basic molecular mechanisms of action and recent progress in the pharmacological modulation of each class of proteins.
spellingShingle Arrowsmith, C
Bountra, C
Fish, P
Lee, K
Schapira, M
Epigenetic protein families: a new frontier for drug discovery.
title Epigenetic protein families: a new frontier for drug discovery.
title_full Epigenetic protein families: a new frontier for drug discovery.
title_fullStr Epigenetic protein families: a new frontier for drug discovery.
title_full_unstemmed Epigenetic protein families: a new frontier for drug discovery.
title_short Epigenetic protein families: a new frontier for drug discovery.
title_sort epigenetic protein families a new frontier for drug discovery
work_keys_str_mv AT arrowsmithc epigeneticproteinfamiliesanewfrontierfordrugdiscovery
AT bountrac epigeneticproteinfamiliesanewfrontierfordrugdiscovery
AT fishp epigeneticproteinfamiliesanewfrontierfordrugdiscovery
AT leek epigeneticproteinfamiliesanewfrontierfordrugdiscovery
AT schapiram epigeneticproteinfamiliesanewfrontierfordrugdiscovery